Bacterial infections Amoxicilline / omeprazol / rifabutin Bedaquiline IND Ceftaroline fosamil IND Ceftazidime / avibactam Zavicefta is indicated in adults and children aged 3 months and older and adolescents for the treatment of the following infections in adults with Complicated intra-abdominal infection (cIAI), Complicated urinary tract infection (cUTI), including pyelonephritis, Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP). IND Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, the currently approved indications for complicated intra-abdominal infection (cIAI), complicated urinary tract infection (cUTI) and hospital-acquired pneumonia, including ventilator-associated pneumonia. IND Ceftobiprole Delafloxacin IND Delamanid IND Iclaprim Imipenem / cilastatin / relebactam Recarbrio is indicated for the treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options. Treatment of hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP), in adults. Treatment of bacteraemia that occurs in association with, or is suspected to be associated with HAP or VAP, in adults. IND Lefamulin Liposomaal amikacine Obiltoxaximab Ozenoxacine Pretomanid SER 109 Tebipenem Tedizolid IND Fungal infections Ibrexafungerp IND Posaconazol IND Rezafungin HIV Atazanavir / cobicistat Cabotegravir Etravirine IND Fostemsavir Lenacapavir Other infectious diseases Human normal immunoglobulin IND Other viral infections APN01 Baloxavir marboxil Bamlanivimab/ etesevimab Baricitinib IND Bulevirtide Casirivimab/imdevimab Dapagliflozine IND Elbasvir / grazoprevir IND Glecaprevir / pibrentasvir IND Lonafarnib Maribavir Nirsevimab Regdanvimab Remdesivir Veklury is geïndiceerd voor de behandeling van coronavirus disease 2019 (COVID-19) bij volwassenen en jongeren (vanaf 12 jaar die minstens 40kg wegen) met pneumonie die aanvullende zuurstof nodig hebben. Extension of indication to include treatment of adults with pneumonia not requiring supplemental oxygen (moderate COVID-19). IND Sotrovimab Tecovirimat Zanamivir